Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd, Astex Therapeutics LtdfiledCriticalGlaxosmithkline Ip Dev Ltd
Priority claimed from PCT/IB2014/067027external-prioritypatent/WO2015092713A1/fr
Publication of MA39115A2publicationCriticalpatent/MA39115A2/fr
Publication of MA39115A3publicationCriticalpatent/MA39115A3/fr
Publication of MA39115B1publicationCriticalpatent/MA39115B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La présente invention concerne des analogues de bisaryle, des compositions pharmaceutiques les contenant et leur utilisation en tant que régulateurs de nrf2.
MA39115A2013-12-182014-12-17Régulateurs de nrf2
MA39115B1
(fr)
Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.